Review



trofinetide  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress trofinetide
    Administration of <t>trofinetide</t> rescues spatial memory deficits in APP/PS1 mice. A Mouse age and experimental design. B , C In the Morris water maze behavioral assessment, the distance and time taken to reach the target platform during the platform learning task ( n = 8 per group). D The number of platform crossings during the spatial probe trial ( n = 8 per group). E The percentage of time spent in the target quadrant during the spatial probe trial ( n = 8 per group). F Representative tracking path from the spatial probe trial. * P < 0.05; ** P < 0.01; *** P < 0.001. The distance and time to reach the target were analyzed using two-way ANOVA, while other data were analyzed using one-way ANOVA with Tukey’s post hoc test. Bar graphs represent the mean ± SEM
    Trofinetide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trofinetide/product/MedChemExpress
    Average 94 stars, based on 4 article reviews
    trofinetide - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis"

    Article Title: Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis

    Journal: Molecular Neurobiology

    doi: 10.1007/s12035-025-05500-5

    Administration of trofinetide rescues spatial memory deficits in APP/PS1 mice. A Mouse age and experimental design. B , C In the Morris water maze behavioral assessment, the distance and time taken to reach the target platform during the platform learning task ( n = 8 per group). D The number of platform crossings during the spatial probe trial ( n = 8 per group). E The percentage of time spent in the target quadrant during the spatial probe trial ( n = 8 per group). F Representative tracking path from the spatial probe trial. * P < 0.05; ** P < 0.01; *** P < 0.001. The distance and time to reach the target were analyzed using two-way ANOVA, while other data were analyzed using one-way ANOVA with Tukey’s post hoc test. Bar graphs represent the mean ± SEM
    Figure Legend Snippet: Administration of trofinetide rescues spatial memory deficits in APP/PS1 mice. A Mouse age and experimental design. B , C In the Morris water maze behavioral assessment, the distance and time taken to reach the target platform during the platform learning task ( n = 8 per group). D The number of platform crossings during the spatial probe trial ( n = 8 per group). E The percentage of time spent in the target quadrant during the spatial probe trial ( n = 8 per group). F Representative tracking path from the spatial probe trial. * P < 0.05; ** P < 0.01; *** P < 0.001. The distance and time to reach the target were analyzed using two-way ANOVA, while other data were analyzed using one-way ANOVA with Tukey’s post hoc test. Bar graphs represent the mean ± SEM

    Techniques Used:

    Trofinetide reduces Aβ burden in APP/PS1 mice. A Representative images of Aβ deposition in the hippocampus and cortex, stained with anti-Aβ42 antibody. Scale bar: 200 µm. B Quantification of plaque numbers in the hippocampus and cortex was performed using brain sections from 3 mice per group. * P < 0.05; ** P < 0.01. Data are expressed as mean ± SEM
    Figure Legend Snippet: Trofinetide reduces Aβ burden in APP/PS1 mice. A Representative images of Aβ deposition in the hippocampus and cortex, stained with anti-Aβ42 antibody. Scale bar: 200 µm. B Quantification of plaque numbers in the hippocampus and cortex was performed using brain sections from 3 mice per group. * P < 0.05; ** P < 0.01. Data are expressed as mean ± SEM

    Techniques Used: Staining

    Effect of trofinetide on pro-inflammatory cytokines expression and microglial activation in APP/PS1 mice, via PPAR-γ/BACE1/NF-κB signaling pathway. A – C ELISA analysis of TNF-α, IL-1β, and IL-6 levels in mice serum ( n = 6 per group). D – G Immunofluorescence staining of Iba1 in the hippocampus and cortex. Scale bar = 50 μm. Quantification was performed on sections from 3 mice per group. H Representative western blot bands showing the expression of PPAR-γ, BACE1, NF-κB, and p-NF-κB in brain tissue from WT, APP/PS1, and APP/PS1 mice treated with trofinetide. I – K Relative grayscale analysis of PPAR-γ and BACE1 normalized to GAPDH, while p-NF-κB levels were analyzed relative to total NF-κB. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, ns = not significant
    Figure Legend Snippet: Effect of trofinetide on pro-inflammatory cytokines expression and microglial activation in APP/PS1 mice, via PPAR-γ/BACE1/NF-κB signaling pathway. A – C ELISA analysis of TNF-α, IL-1β, and IL-6 levels in mice serum ( n = 6 per group). D – G Immunofluorescence staining of Iba1 in the hippocampus and cortex. Scale bar = 50 μm. Quantification was performed on sections from 3 mice per group. H Representative western blot bands showing the expression of PPAR-γ, BACE1, NF-κB, and p-NF-κB in brain tissue from WT, APP/PS1, and APP/PS1 mice treated with trofinetide. I – K Relative grayscale analysis of PPAR-γ and BACE1 normalized to GAPDH, while p-NF-κB levels were analyzed relative to total NF-κB. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, ns = not significant

    Techniques Used: Expressing, Activation Assay, Enzyme-linked Immunosorbent Assay, Immunofluorescence, Staining, Western Blot

    Effect of trofinetide on apoptosis protein expression and neuronal damage in APP/PS1 mice. A –D Representative western blot analysis of caspase-3, Bax, Bcl-2, and GAPDH in the cortex of APP/PS1 mice and WT littermates. E – H Immunofluorescence staining of NeuN in the hippocampus and cortex across different groups. Scale bar = 50 μm. Quantification was performed using brain sections from 3 mice per group. * P < 0.05; ** P < 0.01; *** P < 0.001; bar graphs represent mean ± SEM
    Figure Legend Snippet: Effect of trofinetide on apoptosis protein expression and neuronal damage in APP/PS1 mice. A –D Representative western blot analysis of caspase-3, Bax, Bcl-2, and GAPDH in the cortex of APP/PS1 mice and WT littermates. E – H Immunofluorescence staining of NeuN in the hippocampus and cortex across different groups. Scale bar = 50 μm. Quantification was performed using brain sections from 3 mice per group. * P < 0.05; ** P < 0.01; *** P < 0.001; bar graphs represent mean ± SEM

    Techniques Used: Expressing, Western Blot, Immunofluorescence, Staining

    Effects of trofinetide and AβOs treatment on BV2 and HT22 cell viability. A , D Cell viability of BV2 and HT22 cells after 24 h of AβOs treatment. B , E Cell viability of BV2 and HT22 cells after 24 h of trofinetide treatment. C , F Cell viability of BV2 and HT22 cells after 2 h of pre-treatment with trofinetide, followed by 24 h of treatment with trofinetide and AβOs. * P < 0.05, ** P < 0.01. One-way ANOVA with Tukey’s post hoc test. Bar graphs represent mean ± SD
    Figure Legend Snippet: Effects of trofinetide and AβOs treatment on BV2 and HT22 cell viability. A , D Cell viability of BV2 and HT22 cells after 24 h of AβOs treatment. B , E Cell viability of BV2 and HT22 cells after 24 h of trofinetide treatment. C , F Cell viability of BV2 and HT22 cells after 2 h of pre-treatment with trofinetide, followed by 24 h of treatment with trofinetide and AβOs. * P < 0.05, ** P < 0.01. One-way ANOVA with Tukey’s post hoc test. Bar graphs represent mean ± SD

    Techniques Used:

    PPAR-γ/NF-κB pathway and inflammatory cytokine release in BV2 with AβOs and trofinetide treatment. A – C Western blot analysis of PPAR-γ, NF-κB, and p-NF-κB expression in BV2 cells with AβOs and trofinetide treatment. D mRNA expression levels of TNF-α, IL-1β, and IL-6 in BV2 cells after treatment. E ELISA analysis of TNF-α, IL-1β, and IL-6 secretion levels in BV2 cells after treatment. * P < 0.05, ** P < 0.01, **** P < 0.0001. One-way ANOVA with Tukey’s post hoc test. Bar graphs represent mean ± SD
    Figure Legend Snippet: PPAR-γ/NF-κB pathway and inflammatory cytokine release in BV2 with AβOs and trofinetide treatment. A – C Western blot analysis of PPAR-γ, NF-κB, and p-NF-κB expression in BV2 cells with AβOs and trofinetide treatment. D mRNA expression levels of TNF-α, IL-1β, and IL-6 in BV2 cells after treatment. E ELISA analysis of TNF-α, IL-1β, and IL-6 secretion levels in BV2 cells after treatment. * P < 0.05, ** P < 0.01, **** P < 0.0001. One-way ANOVA with Tukey’s post hoc test. Bar graphs represent mean ± SD

    Techniques Used: Western Blot, Expressing, Enzyme-linked Immunosorbent Assay

    Trofinetide inhibits caspase-3 activation and reduces AβOs-induced apoptosis in HT22 cells. A , B Flow cytometry analysis of apoptosis in HT22 cells with AβOs treatments and trofinetide rescue group. C , D Representative western blots and statistical analyses of cleaved caspase-3, Bax, Bcl-2, and GAPDH in AβOs and trofinetide rescue groups. * P < 0.05, ** P < 0.01. One-way ANOVA with Tukey’s post hoc test. Bar graphs represent mean ± SD
    Figure Legend Snippet: Trofinetide inhibits caspase-3 activation and reduces AβOs-induced apoptosis in HT22 cells. A , B Flow cytometry analysis of apoptosis in HT22 cells with AβOs treatments and trofinetide rescue group. C , D Representative western blots and statistical analyses of cleaved caspase-3, Bax, Bcl-2, and GAPDH in AβOs and trofinetide rescue groups. * P < 0.05, ** P < 0.01. One-way ANOVA with Tukey’s post hoc test. Bar graphs represent mean ± SD

    Techniques Used: Activation Assay, Flow Cytometry, Western Blot



    Similar Products

    94
    MedChemExpress trofinetide
    Administration of <t>trofinetide</t> rescues spatial memory deficits in APP/PS1 mice. A Mouse age and experimental design. B , C In the Morris water maze behavioral assessment, the distance and time taken to reach the target platform during the platform learning task ( n = 8 per group). D The number of platform crossings during the spatial probe trial ( n = 8 per group). E The percentage of time spent in the target quadrant during the spatial probe trial ( n = 8 per group). F Representative tracking path from the spatial probe trial. * P < 0.05; ** P < 0.01; *** P < 0.001. The distance and time to reach the target were analyzed using two-way ANOVA, while other data were analyzed using one-way ANOVA with Tukey’s post hoc test. Bar graphs represent the mean ± SEM
    Trofinetide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trofinetide/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    trofinetide - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    Neuren Inc trofinetide
    Administration of <t>trofinetide</t> rescues spatial memory deficits in APP/PS1 mice. A Mouse age and experimental design. B , C In the Morris water maze behavioral assessment, the distance and time taken to reach the target platform during the platform learning task ( n = 8 per group). D The number of platform crossings during the spatial probe trial ( n = 8 per group). E The percentage of time spent in the target quadrant during the spatial probe trial ( n = 8 per group). F Representative tracking path from the spatial probe trial. * P < 0.05; ** P < 0.01; *** P < 0.001. The distance and time to reach the target were analyzed using two-way ANOVA, while other data were analyzed using one-way ANOVA with Tukey’s post hoc test. Bar graphs represent the mean ± SEM
    Trofinetide, supplied by Neuren Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trofinetide/product/Neuren Inc
    Average 90 stars, based on 1 article reviews
    trofinetide - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    ACADIA Pharmaceuticals trofinetide
    Administration of <t>trofinetide</t> rescues spatial memory deficits in APP/PS1 mice. A Mouse age and experimental design. B , C In the Morris water maze behavioral assessment, the distance and time taken to reach the target platform during the platform learning task ( n = 8 per group). D The number of platform crossings during the spatial probe trial ( n = 8 per group). E The percentage of time spent in the target quadrant during the spatial probe trial ( n = 8 per group). F Representative tracking path from the spatial probe trial. * P < 0.05; ** P < 0.01; *** P < 0.001. The distance and time to reach the target were analyzed using two-way ANOVA, while other data were analyzed using one-way ANOVA with Tukey’s post hoc test. Bar graphs represent the mean ± SEM
    Trofinetide, supplied by ACADIA Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trofinetide/product/ACADIA Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    trofinetide - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    ACADIA Pharmaceuticals trofinetide daybue
    Administration of <t>trofinetide</t> rescues spatial memory deficits in APP/PS1 mice. A Mouse age and experimental design. B , C In the Morris water maze behavioral assessment, the distance and time taken to reach the target platform during the platform learning task ( n = 8 per group). D The number of platform crossings during the spatial probe trial ( n = 8 per group). E The percentage of time spent in the target quadrant during the spatial probe trial ( n = 8 per group). F Representative tracking path from the spatial probe trial. * P < 0.05; ** P < 0.01; *** P < 0.001. The distance and time to reach the target were analyzed using two-way ANOVA, while other data were analyzed using one-way ANOVA with Tukey’s post hoc test. Bar graphs represent the mean ± SEM
    Trofinetide Daybue, supplied by ACADIA Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trofinetide daybue/product/ACADIA Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    trofinetide daybue - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Administration of trofinetide rescues spatial memory deficits in APP/PS1 mice. A Mouse age and experimental design. B , C In the Morris water maze behavioral assessment, the distance and time taken to reach the target platform during the platform learning task ( n = 8 per group). D The number of platform crossings during the spatial probe trial ( n = 8 per group). E The percentage of time spent in the target quadrant during the spatial probe trial ( n = 8 per group). F Representative tracking path from the spatial probe trial. * P < 0.05; ** P < 0.01; *** P < 0.001. The distance and time to reach the target were analyzed using two-way ANOVA, while other data were analyzed using one-way ANOVA with Tukey’s post hoc test. Bar graphs represent the mean ± SEM

    Journal: Molecular Neurobiology

    Article Title: Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis

    doi: 10.1007/s12035-025-05500-5

    Figure Lengend Snippet: Administration of trofinetide rescues spatial memory deficits in APP/PS1 mice. A Mouse age and experimental design. B , C In the Morris water maze behavioral assessment, the distance and time taken to reach the target platform during the platform learning task ( n = 8 per group). D The number of platform crossings during the spatial probe trial ( n = 8 per group). E The percentage of time spent in the target quadrant during the spatial probe trial ( n = 8 per group). F Representative tracking path from the spatial probe trial. * P < 0.05; ** P < 0.01; *** P < 0.001. The distance and time to reach the target were analyzed using two-way ANOVA, while other data were analyzed using one-way ANOVA with Tukey’s post hoc test. Bar graphs represent the mean ± SEM

    Article Snippet: Trofinetide (NNZ-2566, purity > 99%) was purchased from MedChemExpress (NJ, USA), and Aβ42 oligomer powder was obtained from China Peptides Co., Ltd. (Shanghai, China).

    Techniques:

    Trofinetide reduces Aβ burden in APP/PS1 mice. A Representative images of Aβ deposition in the hippocampus and cortex, stained with anti-Aβ42 antibody. Scale bar: 200 µm. B Quantification of plaque numbers in the hippocampus and cortex was performed using brain sections from 3 mice per group. * P < 0.05; ** P < 0.01. Data are expressed as mean ± SEM

    Journal: Molecular Neurobiology

    Article Title: Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis

    doi: 10.1007/s12035-025-05500-5

    Figure Lengend Snippet: Trofinetide reduces Aβ burden in APP/PS1 mice. A Representative images of Aβ deposition in the hippocampus and cortex, stained with anti-Aβ42 antibody. Scale bar: 200 µm. B Quantification of plaque numbers in the hippocampus and cortex was performed using brain sections from 3 mice per group. * P < 0.05; ** P < 0.01. Data are expressed as mean ± SEM

    Article Snippet: Trofinetide (NNZ-2566, purity > 99%) was purchased from MedChemExpress (NJ, USA), and Aβ42 oligomer powder was obtained from China Peptides Co., Ltd. (Shanghai, China).

    Techniques: Staining

    Effect of trofinetide on pro-inflammatory cytokines expression and microglial activation in APP/PS1 mice, via PPAR-γ/BACE1/NF-κB signaling pathway. A – C ELISA analysis of TNF-α, IL-1β, and IL-6 levels in mice serum ( n = 6 per group). D – G Immunofluorescence staining of Iba1 in the hippocampus and cortex. Scale bar = 50 μm. Quantification was performed on sections from 3 mice per group. H Representative western blot bands showing the expression of PPAR-γ, BACE1, NF-κB, and p-NF-κB in brain tissue from WT, APP/PS1, and APP/PS1 mice treated with trofinetide. I – K Relative grayscale analysis of PPAR-γ and BACE1 normalized to GAPDH, while p-NF-κB levels were analyzed relative to total NF-κB. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, ns = not significant

    Journal: Molecular Neurobiology

    Article Title: Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis

    doi: 10.1007/s12035-025-05500-5

    Figure Lengend Snippet: Effect of trofinetide on pro-inflammatory cytokines expression and microglial activation in APP/PS1 mice, via PPAR-γ/BACE1/NF-κB signaling pathway. A – C ELISA analysis of TNF-α, IL-1β, and IL-6 levels in mice serum ( n = 6 per group). D – G Immunofluorescence staining of Iba1 in the hippocampus and cortex. Scale bar = 50 μm. Quantification was performed on sections from 3 mice per group. H Representative western blot bands showing the expression of PPAR-γ, BACE1, NF-κB, and p-NF-κB in brain tissue from WT, APP/PS1, and APP/PS1 mice treated with trofinetide. I – K Relative grayscale analysis of PPAR-γ and BACE1 normalized to GAPDH, while p-NF-κB levels were analyzed relative to total NF-κB. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, ns = not significant

    Article Snippet: Trofinetide (NNZ-2566, purity > 99%) was purchased from MedChemExpress (NJ, USA), and Aβ42 oligomer powder was obtained from China Peptides Co., Ltd. (Shanghai, China).

    Techniques: Expressing, Activation Assay, Enzyme-linked Immunosorbent Assay, Immunofluorescence, Staining, Western Blot

    Effect of trofinetide on apoptosis protein expression and neuronal damage in APP/PS1 mice. A –D Representative western blot analysis of caspase-3, Bax, Bcl-2, and GAPDH in the cortex of APP/PS1 mice and WT littermates. E – H Immunofluorescence staining of NeuN in the hippocampus and cortex across different groups. Scale bar = 50 μm. Quantification was performed using brain sections from 3 mice per group. * P < 0.05; ** P < 0.01; *** P < 0.001; bar graphs represent mean ± SEM

    Journal: Molecular Neurobiology

    Article Title: Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis

    doi: 10.1007/s12035-025-05500-5

    Figure Lengend Snippet: Effect of trofinetide on apoptosis protein expression and neuronal damage in APP/PS1 mice. A –D Representative western blot analysis of caspase-3, Bax, Bcl-2, and GAPDH in the cortex of APP/PS1 mice and WT littermates. E – H Immunofluorescence staining of NeuN in the hippocampus and cortex across different groups. Scale bar = 50 μm. Quantification was performed using brain sections from 3 mice per group. * P < 0.05; ** P < 0.01; *** P < 0.001; bar graphs represent mean ± SEM

    Article Snippet: Trofinetide (NNZ-2566, purity > 99%) was purchased from MedChemExpress (NJ, USA), and Aβ42 oligomer powder was obtained from China Peptides Co., Ltd. (Shanghai, China).

    Techniques: Expressing, Western Blot, Immunofluorescence, Staining

    Effects of trofinetide and AβOs treatment on BV2 and HT22 cell viability. A , D Cell viability of BV2 and HT22 cells after 24 h of AβOs treatment. B , E Cell viability of BV2 and HT22 cells after 24 h of trofinetide treatment. C , F Cell viability of BV2 and HT22 cells after 2 h of pre-treatment with trofinetide, followed by 24 h of treatment with trofinetide and AβOs. * P < 0.05, ** P < 0.01. One-way ANOVA with Tukey’s post hoc test. Bar graphs represent mean ± SD

    Journal: Molecular Neurobiology

    Article Title: Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis

    doi: 10.1007/s12035-025-05500-5

    Figure Lengend Snippet: Effects of trofinetide and AβOs treatment on BV2 and HT22 cell viability. A , D Cell viability of BV2 and HT22 cells after 24 h of AβOs treatment. B , E Cell viability of BV2 and HT22 cells after 24 h of trofinetide treatment. C , F Cell viability of BV2 and HT22 cells after 2 h of pre-treatment with trofinetide, followed by 24 h of treatment with trofinetide and AβOs. * P < 0.05, ** P < 0.01. One-way ANOVA with Tukey’s post hoc test. Bar graphs represent mean ± SD

    Article Snippet: Trofinetide (NNZ-2566, purity > 99%) was purchased from MedChemExpress (NJ, USA), and Aβ42 oligomer powder was obtained from China Peptides Co., Ltd. (Shanghai, China).

    Techniques:

    PPAR-γ/NF-κB pathway and inflammatory cytokine release in BV2 with AβOs and trofinetide treatment. A – C Western blot analysis of PPAR-γ, NF-κB, and p-NF-κB expression in BV2 cells with AβOs and trofinetide treatment. D mRNA expression levels of TNF-α, IL-1β, and IL-6 in BV2 cells after treatment. E ELISA analysis of TNF-α, IL-1β, and IL-6 secretion levels in BV2 cells after treatment. * P < 0.05, ** P < 0.01, **** P < 0.0001. One-way ANOVA with Tukey’s post hoc test. Bar graphs represent mean ± SD

    Journal: Molecular Neurobiology

    Article Title: Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis

    doi: 10.1007/s12035-025-05500-5

    Figure Lengend Snippet: PPAR-γ/NF-κB pathway and inflammatory cytokine release in BV2 with AβOs and trofinetide treatment. A – C Western blot analysis of PPAR-γ, NF-κB, and p-NF-κB expression in BV2 cells with AβOs and trofinetide treatment. D mRNA expression levels of TNF-α, IL-1β, and IL-6 in BV2 cells after treatment. E ELISA analysis of TNF-α, IL-1β, and IL-6 secretion levels in BV2 cells after treatment. * P < 0.05, ** P < 0.01, **** P < 0.0001. One-way ANOVA with Tukey’s post hoc test. Bar graphs represent mean ± SD

    Article Snippet: Trofinetide (NNZ-2566, purity > 99%) was purchased from MedChemExpress (NJ, USA), and Aβ42 oligomer powder was obtained from China Peptides Co., Ltd. (Shanghai, China).

    Techniques: Western Blot, Expressing, Enzyme-linked Immunosorbent Assay

    Trofinetide inhibits caspase-3 activation and reduces AβOs-induced apoptosis in HT22 cells. A , B Flow cytometry analysis of apoptosis in HT22 cells with AβOs treatments and trofinetide rescue group. C , D Representative western blots and statistical analyses of cleaved caspase-3, Bax, Bcl-2, and GAPDH in AβOs and trofinetide rescue groups. * P < 0.05, ** P < 0.01. One-way ANOVA with Tukey’s post hoc test. Bar graphs represent mean ± SD

    Journal: Molecular Neurobiology

    Article Title: Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis

    doi: 10.1007/s12035-025-05500-5

    Figure Lengend Snippet: Trofinetide inhibits caspase-3 activation and reduces AβOs-induced apoptosis in HT22 cells. A , B Flow cytometry analysis of apoptosis in HT22 cells with AβOs treatments and trofinetide rescue group. C , D Representative western blots and statistical analyses of cleaved caspase-3, Bax, Bcl-2, and GAPDH in AβOs and trofinetide rescue groups. * P < 0.05, ** P < 0.01. One-way ANOVA with Tukey’s post hoc test. Bar graphs represent mean ± SD

    Article Snippet: Trofinetide (NNZ-2566, purity > 99%) was purchased from MedChemExpress (NJ, USA), and Aβ42 oligomer powder was obtained from China Peptides Co., Ltd. (Shanghai, China).

    Techniques: Activation Assay, Flow Cytometry, Western Blot